NUDT15

Nudix Hydrolase 15 – Key Regulator of Thiopurine Metabolism and Toxicity

Gene Information Card

Symbol NUDT15
Full Name Nudix Hydrolase 15
Gene Type Protein coding
Chromosomal Location 13q14.2
NCBI Gene ID 55270 ncbi.nlm.nih.gov/gene/55270
Ensembl ID ENSG00000165731
UniProt ID Q9BV35
OMIM ID 615792
HGNC ID 23019
Aliases MTH2, NUDT15D, NUDT15L, hNUDT15

Description

NUDT15 encodes a member of the nudix hydrolase superfamily that hydrolyzes nucleoside diphosphates linked to other moieties (e.g., dGTP, dTTP, and thiopurine metabolites). It is a key enzyme in the detoxification of thiopurine drugs (6-mercaptopurine, azathioprine) by converting active thioguanine nucleotides to inactive metabolites. Loss-of-function variants in NUDT15 are strongly associated with thiopurine-induced myelosuppression and leukopenia, particularly in East Asian and Hispanic populations.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Thiopurine-induced myelosuppression Loss-of-function NUDT15 variants reduce clearance of active thioguanine nucleotides, leading to accumulation and bone marrow toxicity ClinVar, multiple GWAS studies
Acute lymphoblastic leukemia (ALL) treatment toxicity NUDT15 deficiency increases risk of severe leukopenia during 6-mercaptopurine therapy ClinVar, COSMIC
Inflammatory bowel disease (IBD) thiopurine intolerance NUDT15 variants predict early thiopurine discontinuation due to leukopenia ClinVar, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Bone marrow 12.3 Medium
Spleen 8.7 Medium
Liver 6.5 Low
Small intestine 5.2 Low
Whole blood 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
K-562 (leukemia) 15.2 High expression
HEK 293 (embryonic kidney) 9.8 Medium expression
HepG2 (liver) 7.3 Medium expression
HL-60 (promyeloblast) 6.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs116855232 (p.Arg139Cys) Missense 9-15% in East Asians; <1% in Europeans Loss-of-function; reduced thiopurine metabolism
rs186364861 (p.Val18Ile) Missense 2-5% in East Asians Loss-of-function; increased toxicity risk
rs746071566 (p.Arg139His) Missense Rare Loss-of-function; associated with leukopenia
rs147390019 (c.415C>T) Nonsense Rare Loss-of-function; premature stop codon
Mutation functional classification

Loss of Function (LOF)

Common NUDT15 variants (e.g., p.Arg139Cys, p.Val18Ile) reduce enzymatic activity, leading to accumulation of toxic thioguanine nucleotides and increased risk of myelosuppression.

Gain of Function (GOF)

No gain-of-function variants have been clinically characterized for NUDT15.

Dominant Negative (DN)

No dominant-negative effects have been reported for NUDT15.

Pathways

Thiopurine metabolism (Reactome: R-HSA-156581)
Purine metabolism (KEGG: hsa00230)
Drug metabolism – other enzymes (KEGG: hsa00983)

Protein Summary

NUDT15 is a 164-amino acid nudix hydrolase that catalyzes the hydrolysis of nucleoside diphosphates, including dGTP, dTTP, and the active thiopurine metabolites (e.g., thioguanine diphosphate). It protects cells from nucleotide pool imbalances and drug toxicity. The protein is predominantly cytoplasmic and expressed in hematopoietic tissues. Loss-of-function mutations reduce thiopurine clearance, leading to severe leukopenia in treated patients.

Related Products

Product name Cat.No. Species Gene ID
NUDT15 Knockout HEK293 Cell Line EDJ-KQ14516 Human 55270 Details Get a Quote
NUDT15 Knockout A-549 Cell Line EDJ-KQ44790 Human 55270 Details Get a Quote
NUDT15 Knockout HCT 116 Cell Line EDJ-KQ44791 Human 55270 Details Get a Quote
NUDT15 Knockout HeLa Cell Line EDJ-KQ44792 Human 55270 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: